Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
University of Washington
Fred Hutchinson Cancer Center
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Center for International Blood and Marrow Transplant Research
University of Southern California
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Ryvu Therapeutics SA
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Incyte Corporation
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Italfarmaco
Fred Hutchinson Cancer Center
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Ottawa Hospital Research Institute
GlaxoSmithKline
Telios Pharma, Inc.
Incyte Corporation
M.D. Anderson Cancer Center
University of Birmingham
Celgene
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Alabama at Birmingham
Incyte Corporation
University of Utah
Hoffmann-La Roche
Geron Corporation
Icahn School of Medicine at Mount Sinai